Exhale

The official blog of the Lung Institute.

Is Bronchiectasis Curable?

Lung Graphic

There is no treatment that can cure bronchiectasis at this time. However, while researchers are still exploring potential cures, people who are living with the condition do have a variety of options for managing their symptoms. These include traditional treatments such as medications and supplemental oxygen to make breathing easier, antibiotics and vaccinations to prevent respiratory infections, physiotherapy and breathing exercises to help clear the airway, and pulmonary rehabilitation to help improve lung function. Some patients also consider alternative forms of bronchiectasis treatment, such as cellular therapy, to further alleviate their symptoms.

While cellular therapy is not capable of reversing existing damage, it does have the potential to help slow the progression of inflammation and chronic lung disease. People who undergo cellular therapy as a form of bronchiectasis treatment may also experience a number of quality of life benefits, including:

  • An improvement in the severity and frequency of their symptoms
  • A reduced dependence on supplemental oxygen
  • Less difficulty working, exercising and participating in normal daily activities

At the Lung Institute, we proudly offer cellular therapy for bronchiectasis treatment. We are the only cellular therapy center in the world to focus exclusively on the treatment of lung-related disorders, and our patients directly benefit from our unparalleled expertise. We offer cellular therapy so that patients can receive the bronchiectasis treatment option that’s most appropriate for their needs.

For more information about bronchiectasis treatment and the benefits that cellular therapy can provide, contact the Lung Institute at (800) 729-3065. We have a compassionate team of professionals that can help you determine if cellular therapy is right for you.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.